查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球顯影劑劑注射器市場：按產品類型、按應用、按最終用戶、按地區 - 預測至 2029 年
市場調查報告書
商品編碼
1512223

全球顯影劑劑注射器市場：按產品類型、按應用、按最終用戶、按地區 - 預測至 2029 年

Contrast Media Injectors Market by Product (System, Consumable, Accessories), Type, Application, End user, & Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 200 Pages | 訂單完成後即時交付

價格
簡介目錄

全球顯影劑注射器市場規模預計將從2024年的16億美元增加到2029年的23億美元，2024年至2029年的複合年成長率為8.0%。

人口老化，加上癌症和心臟病的增加，對這些產品的需求不斷增加。心血管疾病在老年族群中較為常見。顯影劑有助於可視化血管並提高診斷可靠性。此外，顯影劑導的手術的日益成長的益處正在推動對顯影劑注射器的需求。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（美元）
按細分市場 按產品類型、按應用、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

依產品分類，顯影劑注射器市場分為注射器系統、消耗品和配件。顯影劑消耗品是用於管理診斷顯影劑的各種產品，例如注射器、管子、管瓶/瓶子和靜脈輸液器。慢性病的增加和對早期診斷的需求導致診斷影像的增加，從而推動了對顯影劑耗材的需求。

顯影劑注射器市場按類型分為雙頭、單頭和無注射器。心臟病患病率的上升和新興國家商業機會的擴大正在推動這一領域的發展。中國有很多公司提供顯影劑注射器和耗材。這些公司採取的專注於技術創新和擴大地理影響力的策略為整體市場成長提供了有利的機會。雙頭注射器具有顯著的優點，例如提高工作流程效率和增強安全性。近年來，新型雙頭注射器的推出推動了最終用戶設施的採用。

依應用分類，顯影劑注射器市場分為介入性放射學、介入性心臟病學和放射學。放射科是主要細分市場，到2023年將佔據顯影劑注射器市場的最大佔有率。人口老化加劇導致慢性病發生率上升。這最終推動了顯影劑注射器的採用。旨在早期發現症狀的宣傳活動的增加也有助於診斷影像掃描的增加，最終支持最終用戶設施中採用顯影劑。

依最終用戶分類，顯影劑注射器市場分為醫院和診斷影像中心。到 2023 年，醫院將佔據最終用戶市場佔有率的大部分。對老年人群微創治療的重視以及對安裝先進診斷影像設備的津貼的增加正在推動顯影劑輸液設備融入醫院環境。診斷成像中心數量的增加以滿足對診斷成像設備不斷成長的需求以及人口老化的持續成長預計將支持該領域的成長。

該報告研究了全球顯影劑注射器市場，包括按產品類型、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 監管分析
  • 退款場景
  • 投資金籌措場景
  • 價格分析
  • 貿易分析
  • 專利分析
  • 波特五力分析
  • 2024-2025年重大會議和活動
  • 案例研究分析
  • 技術分析
  • 影響客戶業務的趨勢/干擾
  • 主要相關人員和採購標準
  • 未滿足的需求和主要問題
  • 顯影劑劑注射器市場中的人工智慧 (AI)

第6章顯影劑市場（依產品）

  • 介紹
  • 注射系統
  • 消耗品
  • 配件

第7章顯影劑市場（按類型）

  • 介紹
  • 單頭注射器
  • 雙頭注射器
  • 無注射器注射器

第8章顯影劑市場（按應用）

  • 介紹
  • 放射科
  • 介入性心臟病學
  • 介入放射學

第 9 章顯影劑注射器市場（按最終用戶）

  • 介紹
  • 醫院
  • 影像診斷中心

第10章顯影劑市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第11章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 收益分析
  • 市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 公司評價及財務指標
  • 品牌/產品比較
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • BAYER AG
    • BRACCO IMAGING SPA
    • GUERBET
    • ULRICH GMBH & CO. KG
    • MEDTRON AG
    • NEMOTO KYORINDO CO., LTD.
    • SHENZHEN ANKE HIGH-TECH CO., LTD.
    • SINO MDT
    • APOLLO RT CO., LTD.
    • SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
    • SHENZHEN ANTMED CO., LTD.
    • SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.
    • UNION MEDICAL SHENZHEN CO., LTD.
    • SPECTRUM MEDICAL TECHNOLOGIES
    • SHENZHEN BOON MEDICAL SUPPLY CO., LTD.
  • 其他公司
    • SCW MEDICATH LTD.：COMPANY OVERVIEW
    • VYGON：COMPANY OVERVIEW
    • NANJING FOINOE CO., LTD.：COMPANY OVERVIEW
    • LEMER PAX：COMPANY OVERVIEW
    • COMECER SPA：COMPANY OVERVIEW
    • TEMA SINERGIE SPA：COMPANY OVERVIEW
    • SHEEN MAN CO., LTD.：COMPANY OVERVIEW
    • HONG KONG MEDI CO., LTD.：COMPANY OVERVIEW
    • QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.：COMPANY OVERVIEW
    • SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD：COMPANY OVERVIEW

第13章附錄

簡介目錄
Product Code: MD 5244

The global contrast media injectors market is expected to reach USD 2.3 billion by 2029 from USD 1.6 billion in 2024, at a CAGR of 8.0% from 2024 to 2029. Aging population, coupled with a rise in cancer and heart diseases, has increased the demand for these products. Cardiovascular diseases are more prevalent in old-age population. Contrast media helps to better visualize the blood vessels and improves diagnostic confidence. Moreover, increased benefits of contrast-mediated procedures have driven demand for contrast media injectors.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsBy Product, type, application, end user, and region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The consumables segment of product segment held the largest share of the market in 2023"

The contrast media injectors market is segmented based on product into injector systems, consumables, and accessories. Contrast media consumables, like - syringes, tubing, vials and bottles, IV sets, etc., are the various products used to administer contrast agents for imaging procedures. The rising prevalence of chronic diseases and the growing demand for early diagnosis have led to an increase in diagnostic imaging procedures, boosting the demand for contrast media consumables.

"The dual-head injector segment of type segment held the largest share of the market in 2023"

The contrast media injectors market is segmented based on type into dual-head, single head, syringeless. The rising prevalence of heart diseases and growing opportunities in emerging countries drives this segment. There are number of companies providing contrast media injectors and consumables in China. Focus on innovation and strategies adopted by these players to expand their geographic presence offers lucrative opportunity for the growth of overall market. Dual-head injectors have notable benefits such as improved workflow efficiency and enhanced safety. The launch of new dual-head injectors in past few years has supported its adoption in end user facilities.

"The radiology segment for application segment to hold the largest market share in 2023".

Based on application, the contrast media injectors market is segmented into interventional radiology, interventional cardiology, and radiology. Radiology was the major segment, accounting for the largest contrast media injectors market share in 2023. The rising incidence of chronic conditions is supported by the increasing aging population. This ultimately drives the adoption of contrast media injectors. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing number of diagnostic imaging scans that ultimately support the adoption of contrast media injectors in end-user facilities.

"The diagnostic imaging centers segment for the end user segment is projected to register a significant CAGR during the forecast period."

The contrast media injectors market is segmented by end-users into hospitals and diagnostic imaging centers. The hospitals accounted for a major end-user market share in 2023. The emphasis on minimally invasive treatment among the old-age population and increasing grants for the installation of advanced imaging equipment are driving the integration of contrast media injectors into hospital settings. Rising number of diagnostic imaging centers to fulfill the growing demand for imaging equipment and consistent rise in old-age population is expected to support the growth of this segment.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

Increased investment in healthcare infrastructure and services, especially in emerging economies, supports the expansion of diagnostic imaging and, consequently, the demand for contrast injectors. Key players in the market are focusing on expanding their presence in Asia Pacific market to cater the increasing demand for diagnostic scans. Moreover, the proliferation of diagnostic centers, particularly in APAC region, increases the availability and accessibility of imaging services, further driving the demand for contrast media injectors.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
  • By Designation: Director-level-10%, C-level-14%, and Others-76%
  • By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and the Middle East & Africa-2%

The prominent players in the contrast media injectors market are Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Ulrich GmbH & Co. Kg (Germany), and Nemoto Kyorindo (Japan), Sino MDT (China)among others.

Research Coverage

This report studies the contrast media injectors market based on product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall contrast media injectors market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing prevalence of cancer and cardiovascular diseases, growing adoption of contrast-mediated CT and MRI procedures, growing approvals of contrast media), restraints (high cost of contrast media injectors systems), opportunities (rising healthcare expenditure across emerging countries), and challenges (dearth of trained professionals) influencing the growth of the contrast media injectors market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the contrast media injectors market
  • Market Development: Comprehensive information about lucrative markets-the report analyses the contrast media injectors market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media injectors market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Bayer AG (Germany), Guerbet (France), Bracco Imaging S.p.A. (Italy), Ulrich GmbH & Co. Kg (Germany), Medtron AG (Germany), and Nemoto Kyorindo (Japan).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
      • 2.2.1.2 Approach 2: Customer-based market estimation
    • FIGURE 6 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
      • 2.2.1.3 Growth forecast
      • 2.2.1.4 CAGR projections
    • FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • 2.3 DATA TRIANGULATION METHODOLOGY
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 MARKET SHARE ASSESSMENT
    • 2.5.1 STUDY ASSUMPTIONS
    • 2.5.2 GROWTH RATE ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT ANALYSIS
  • 2.7 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 CONTRAST MEDIA INJECTORS MARKET, PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 10 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 GEOGRAPHIC SNAPSHOT OF CONTRAST MEDIA INJECTORS MARKET

4 PREMIUM INSIGHTS

  • 4.1 CONTRAST MEDIA INJECTORS MARKET OVERVIEW
    • FIGURE 14 GROWING ADOPTION OF CONTRAST-MEDIATED CT AND MRI DIAGNOSTIC PROCEDURES TO DRIVE MARKET
  • 4.2 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT AND COUNTRY (2023)
    • FIGURE 15 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
  • 4.3 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 16 INTERVENTIONAL CARDIOLOGY SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 17 DIAGNOSTIC IMAGING CENTERS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.5 CONTRAST MEDIA INJECTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 EMERGING MARKETS PROJECTED TO REACH HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 CONTRAST MEDIA INJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of cancer and cardiovascular diseases
    • FIGURE 20 NEWLY DIAGNOSED CANCER CASES (MILLION)
    • TABLE 2 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2020 VS. 2030 VS. 2040
      • 5.2.1.2 Increasing volume of contrast-mediated MRI and CT procedures
    • TABLE 3 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019-2021
    • TABLE 4 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019-2021
      • 5.2.1.3 Growing approvals for CT and MRI contrast media to fuel demand for injectors
      • 5.2.1.4 Favorable reimbursements in developed markets
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of contrast media injectors
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth potential of emerging economies
      • 5.2.3.2 Growing focus on mammography and nuclear imaging injectors
      • 5.2.3.3 IT-enabled injector solutions
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals and limited technical expertise
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & DEVELOPMENT
    • 5.3.2 MANUFACTURING & ASSEMBLY
    • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
    • FIGURE 21 CONTRAST MEDIA INJECTORS MARKET: VALUE CHAIN ANALYSIS
  • 5.4 SUPPLY CHAIN ANALYSIS
    • 5.4.1 PROMINENT COMPANIES
    • 5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.4.3 END USERS
    • FIGURE 22 CONTRAST MEDIA INJECTORS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 23 PARENT MARKET: ECOSYSTEM ANALYSIS
    • TABLE 5 CONTRAST MEDIA INJECTORS MARKET: ROLE IN ECOSYSTEM
  • 5.6 REGULATORY ANALYSIS
    • TABLE 6 REGULATORY APPROVALS REQUIRED FOR CONTRAST MEDIA INJECTORS, BY COUNTRY
    • 5.6.1 REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.1 North America: Regulatory bodies and government agencies
    • TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.2 Europe: Regulatory bodies and government agencies
    • TABLE 8 EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.3 Asia Pacific: Regulatory bodies and government agencies
    • TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.4 Latin America: Regulatory bodies and government agencies
    • TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
      • 5.6.1.5 Middle East & Africa: Regulatory bodies and government agencies
    • TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
    • 5.6.2 REGULATORY GUIDELINES
      • 5.6.2.1 US
    • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
      • 5.6.2.2 Canada
    • TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
      • 5.6.2.3 Europe
    • FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
      • 5.6.2.4 Asia Pacific
        • 5.6.2.4.1 Japan
    • TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
        • 5.6.2.4.2 China
    • TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
        • 5.6.2.4.3 India
        • 5.6.2.4.4 Brazil
  • 5.7 REIMBURSEMENT SCENARIO
    • TABLE 17 MEDICAL REIMBURSEMENT CODES FOR CONTRAST MEDIA IN US, 2023
  • 5.8 INVESTMENT & FUNDING SCENARIO
    • FIGURE 27 NUMBER OF DEALS & FUNDING INITIATIVES IN CONTRAST MEDIA INJECTORS MARKET, 2018-2022 (USD MILLION)
    • FIGURE 28 NUMBER OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018-2022
    • FIGURE 29 VALUE OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • 5.9 PRICING ANALYSIS
    • FIGURE 30 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY PRODUCT
    • FIGURE 31 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY REGION
    • TABLE 18 AVERAGE SELLING PRICE OF CONTRAST MEDIA INJECTORS, BY REGION
  • 5.10 TRADE ANALYSIS
    • TABLE 19 IMPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2019-2023 (USD THOUSAND)
    • TABLE 20 EXPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2018-2022 (USD THOUSAND)
  • 5.11 PATENT ANALYSIS
    • FIGURE 32 PATENT ANALYSIS: CONTRAST MEDIA INJECTORS MARKET (2013-2023)
  • 5.12 PORTER'S FIVE FORCE ANALYSIS
    • TABLE 21 PORTER'S FIVE FORCES ANALYSIS: CONTRAST MEDIA INJECTORS MARKET
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY CONFERENCES & EVENTS IN 2024-2025
    • TABLE 22 LIST OF MAJOR CONFERENCES & EVENTS IN CONTRAST MEDIA INJECTORS MARKET, 2024-2025
  • 5.14 CASE STUDY ANALYSIS
    • TABLE 23 CASE STUDY 1: CARDIAC ENHANCEMENT ANALYSIS VIA CONTRAST MEDIA INJECTORS
  • 5.15 TECHNOLOGY ANALYSIS
    • 5.15.1 KEY TECHNOLOGIES
      • 5.15.1.1 MRI contrast media injectors
      • 5.15.1.2 CT contrast media injectors
      • 5.15.1.3 Angiography contrast media injectors
    • 5.15.2 COMPLEMENTARY TECHNOLOGIES
      • 5.15.2.1 Diagnostic imaging modalities
    • 5.15.3 ADJACENT TECHNOLOGIES
      • 5.15.3.1 Artificial intelligence with automated data systems
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 33 REVENUE SHIFT IN CONTRAST MEDIA INJECTORS MARKET
  • 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRIMARY FACTORS
    • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • FIGURE 35 BUYING CRITERIA FOR END USERS
    • TABLE 25 INFLUENCE OF END USERS ON BUYING PROCESS
    • FIGURE 36 INFLUENCE OF STAKEHOLDERS. BY END USER
    • TABLE 26 INFLUENCE OF STAKEHOLDERS, BY END USER
    • 5.17.2 BUYING CRITERIA
    • FIGURE 37 KEY BUYING CRITERIA FOR PROCESS CONTRAST MEDIA INJECTORS
    • TABLE 27 KEY BUYING CRITERIA FOR CONTRAST MEDIA INJECTORS
  • 5.18 UNMET NEEDS & KEY PAIN POINTS
    • TABLE 28 CONTRAST MEDIA INJECTORS MARKET: CURRENT UNMET NEEDS
  • 5.19 ARTIFICIAL INTELLIGENCE (AI) IN CONTRAST MEDIA INJECTORS MARKET

6 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 29 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • 6.2 INJECTOR SYSTEMS
    • TABLE 30 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 31 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.1 CT INJECTORS
      • 6.2.1.1 Increasing number of CT scans to boost demand
    • TABLE 32 CT INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.2 MRI INJECTORS
      • 6.2.2.1 Rising funding initiatives for development of advanced systems to propel market
    • TABLE 33 MRI INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.3 ANGIOGRAPHY INJECTORS
      • 6.2.3.1 High uptake of cardiac catheterization procedures to drive market
    • TABLE 34 ANGIOGRAPHY INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.2.4 OTHER INJECTORS
  • 6.3 CONSUMABLES
    • TABLE 35 CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 36 CONTRAST MEDIA CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.1 SYRINGES
      • 6.3.1.1 Diverse size range to fuel uptake
    • TABLE 37 SYRINGES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.2 TUBES
      • 6.3.2.1 Increasing demand for single-use products to drive market
    • TABLE 38 TUBES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.3 OTHER CONSUMABLES
    • TABLE 39 OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 6.4 ACCESSORIES
    • 6.4.1 ABILITY TO ENHANCE WORKFLOW EFFICIENCY TO SUPPORT MARKET GROWTH
    • TABLE 40 CONTRAST MEDIA ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)

7 CONTRAST MEDIA INJECTORS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 41 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 7.2 SINGLE-HEAD INJECTORS
    • 7.2.1 COST-EFFICIENT AND USER-FRIENDLY DESIGN TO PROPEL MARKET
    • TABLE 42 CONTRAST MEDIA INJECTORS MARKET FOR SINGLE-HEAD INJECTORS, BY REGION, 2022-2029 (USD MILLION)
  • 7.3 DUAL-HEAD INJECTORS
    • 7.3.1 PRECISE CONTROL AND ENHANCED PATIENT SAFETY TO BOOST DEMAND
    • TABLE 43 CONTRAST MEDIA INJECTORS MARKET FOR DUAL-HEAD INJECTORS, BY REGION, 2022-2029 (USD MILLION)
  • 7.4 SYRINGELESS INJECTORS
    • 7.4.1 DIRECT ADMINISTRATION VIA TUBING TO SUPPORT MARKET GROWTH
    • TABLE 44 CONTRAST MEDIA INJECTORS MARKET FOR SYRINGELESS INJECTORS, BY REGION, 2022-2029 (USD MILLION)

8 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 45 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 8.2 RADIOLOGY
    • 8.2.1 RISING NUMBER OF RADIOLOGY PROCEDURES TO DRIVE MARKET
    • TABLE 46 CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • 8.3 INTERVENTIONAL CARDIOLOGY
    • 8.3.1 RISING UPTAKE OF CORONARY CT ANGIOGRAMS TO PROPEL MARKET
    • TABLE 47 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022-2029 (USD MILLION)
  • 8.4 INTERVENTIONAL RADIOLOGY
    • 8.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
    • TABLE 48 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2022-2029 (USD MILLION)

9 CONTRAST MEDIA INJECTORS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 49 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2 HOSPITALS
    • 9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO SUPPORT MARKET GROWTH
    • TABLE 50 CONTRAST MEDIA INJECTORS MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • 9.3 DIAGNOSTIC IMAGING CENTERS
    • 9.3.1 INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
    • TABLE 51 CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022-2029 (USD MILLION)

10 CONTRAST MEDIA INJECTORS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 52 CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 38 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
    • TABLE 53 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 54 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 55 NORTH AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 56 NORTH AMERICA: CONTRAST MEDIA INJECTORS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 57 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 58 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 59 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • 10.2.2 US
      • 10.2.2.1 Rising adoption of technologically advanced products to drive market
    • TABLE 60 US: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 61 US: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 62 US: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Rising investments in medical imaging equipment to drive market
    • TABLE 63 CANADA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 64 CANADA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 65 CANADA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 66 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 67 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 68 EUROPE: CONTRAST MEDIA INJECTORS SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 69 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 70 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 71 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.1 EUROPE: RECESSION IMPACT
    • 10.3.2 GERMANY
      • 10.3.2.1 Advancements in imaging technologies to fuel uptake
    • TABLE 72 GERMANY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 73 GERMANY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 74 GERMANY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing prevalence of cancer to propel market
    • TABLE 75 FRANCE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 76 FRANCE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 77 FRANCE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.4 UK
      • 10.3.4.1 High incidence of CVD to propel market
    • TABLE 78 UK: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 79 UK: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 80 UK: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Rising incidence of chronic diseases to support market growth
    • TABLE 81 ITALY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 82 ITALY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 83 ITALY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Shortage of skilled radiologists to restrain market
    • TABLE 84 SPAIN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 85 SPAIN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 86 SPAIN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 87 REST OF EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 88 REST OF EUROPE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 89 REST OF EUROPE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 39 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
    • TABLE 90 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 91 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising geriatric population and subsequent increase in chronic diseases to drive market
    • TABLE 96 JAPAN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 97 JAPAN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 98 JAPAN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.3 CHINA
      • 10.4.3.1 Rising incidence of cancer and increasing establishment of hospitals to boost demand
    • TABLE 99 CHINA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 100 CHINA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 101 CHINA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Growing investments in radiology to propel market
    • TABLE 102 INDIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 103 INDIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 104 INDIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Increasing R&D investments for advanced diagnostic modalities to drive market
    • TABLE 105 AUSTRALIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 106 AUSTRALIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 107 AUSTRALIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Favorable reimbursements for diagnostic procedures to support market growth
    • TABLE 108 SOUTH KOREA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 109 SOUTH KOREA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 110 SOUTH KOREA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.4.7 REST OF ASIA PACIFIC
    • TABLE 111 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 112 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 113 REST OF ASIA PACIFIC: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 114 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 115 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 116 LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 117 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 118 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 119 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • 10.5.2 BRAZIL
      • 10.5.2.1 Growing awareness of early disease detection & diagnosis to drive market
    • TABLE 120 BRAZIL: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 121 BRAZIL: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 122 BRAZIL: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Inadequate healthcare infrastructure to restrain market
    • TABLE 123 MEXICO: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 124 MEXICO: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 125 MEXICO: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 10.5.4 REST OF LATIN AMERICA
    • TABLE 126 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 127 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 128 REST OF LATIN AMERICA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
    • TABLE 129 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 130 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 131 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 132 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 133 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET
    • TABLE 134 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • 11.3 REVENUE ANALYSIS
    • FIGURE 40 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CONTRAST MEDIA INJECTORS MARKET (2019-2023)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
    • TABLE 135 CONTRAST MEDIA INJECTORS MARKET: DEGREE OF COMPETITION
    • 11.4.1 RANKING OF KEY MARKET PLAYERS
    • FIGURE 42 RANKING OF KEY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 43 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
    • FIGURE 44 CONTRAST MEDIA INJECTORS MARKET: COMPANY FOOTPRINT
      • 11.5.5.2 Product footprint
    • TABLE 136 CONTRAST MEDIA INJECTORS MARKET: PRODUCT FOOTPRINT
      • 11.5.5.3 Application footprint
    • TABLE 137 CONTRAST MEDIA INJECTORS MARKET: APPLICATION FOOTPRINT
      • 11.5.5.4 End-user footprint
    • TABLE 138 CONTRAST MEDIA INJECTORS MARKET: END-USER FOOTPRINT
      • 11.5.5.5 Region footprint
    • TABLE 139 CONTRAST MEDIA INJECTORS MARKET: REGION FOOTPRINT
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 45 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • TABLE 140 CONTRAST MEDIA INJECTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
    • TABLE 141 CONTRAST MEDIA INJECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • FIGURE 46 EV/EBITDA OF KEY VENDORS
    • 11.7.2 COMPANY VALUATION
    • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 11.8 BRAND/PRODUCT COMPARISON
    • FIGURE 48 CONTRAST MEDIA INJECTORS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 142 CONTRAST MEDIA INJECTORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • 11.9.2 DEALS
    • TABLE 143 CONTRAST MEDIA INJECTORS MARKET: DEALS, JANUARY 2021-MAY 2024
    • 11.9.3 EXPANSIONS
    • TABLE 144 CONTRAST MEDIA INJECTORS MARKET: EXPANSIONS, JANUARY 2021-MAY 2024

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)**
    • 12.1.1 BAYER AG
    • TABLE 145 BAYER AG: COMPANY OVERVIEW
    • FIGURE 49 BAYER AG: COMPANY SNAPSHOT (2023)
    • TABLE 146 BAYER AG: PRODUCTS OFFERED
    • TABLE 147 BAYER AG: DEALS, JANUARY 2021-MAY 2024
    • 12.1.2 BRACCO IMAGING S.P.A.
    • TABLE 148 BRACCO IMAGING S.P.A.: COMPANY OVERVIEW
    • TABLE 149 BRACCO IMAGING S.P.A.: PRODUCTS OFFERED
    • TABLE 150 BRACCO IMAGING S.P.A.: DEALS, JANUARY 2021-MAY 2024
    • TABLE 151 BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2021-MAY 2024
    • 12.1.3 GUERBET
    • TABLE 152 GUERBET: COMPANY OVERVIEW
    • FIGURE 50 GUERBET: COMPANY SNAPSHOT (2023)
    • TABLE 153 GUERBET: PRODUCTS OFFERED
    • TABLE 154 GUERBET: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024
    • 12.1.4 ULRICH GMBH & CO. KG
    • TABLE 155 ULRICH GMBH & CO. KG: COMPANY OVERVIEW
    • TABLE 156 ULRICH GMBH & CO. KG: PRODUCTS OFFERED
    • TABLE 157 ULRICH GMBH & CO. KG: DEALS, JANUARY 2021-MAY 2024
    • 12.1.5 MEDTRON AG
    • TABLE 158 MEDTRON AG.: COMPANY OVERVIEW
    • TABLE 159 MEDTRON AG: PRODUCTS OFFERED
    • TABLE 160 MEDTRON AG: DEALS, JANUARY 2021-MAY 2024
    • 12.1.6 NEMOTO KYORINDO CO., LTD.
    • TABLE 161 NEMOTO KYORINDO CO., LTD.: COMPANY OVERVIEW
    • TABLE 162 NEMOTO KYORINDO CO., LTD.: PRODUCTS OFFERED
    • 12.1.7 SHENZHEN ANKE HIGH-TECH CO., LTD.
    • TABLE 163 SHENZHEN ANKE HIGH-TECH CO., LTD.: COMPANY OVERVIEW
    • TABLE 164 SHENZHEN ANKE HIGH-TECH CO., LTD.: PRODUCTS OFFERED
    • 12.1.8 SINO MDT
    • TABLE 165 SINO MDT: COMPANY OVERVIEW
    • TABLE 166 SINO MDT: PRODUCTS OFFERED
    • 12.1.9 APOLLO RT CO., LTD.
    • TABLE 167 APOLLO RT CO., LTD.: COMPANY OVERVIEW
    • TABLE 168 APOLLO RT CO., LTD.: PRODUCTS OFFERED
    • 12.1.10 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
    • TABLE 169 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY OVERVIEW
    • TABLE 170 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCTS OFFERED
    • 12.1.11 SHENZHEN ANTMED CO., LTD.
    • TABLE 171 SHENZHEN ANTMED CO., LTD.: COMPANY OVERVIEW
    • TABLE 172 SHENZHEN ANTMED CO., LTD.: PRODUCTS OFFERED
    • 12.1.12 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.
    • TABLE 173 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • TABLE 174 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
    • 12.1.13 UNION MEDICAL SHENZHEN CO., LTD.
    • TABLE 175 UNION MEDICAL SHENZHEN CO., LTD.: COMPANY OVERVIEW
    • TABLE 176 UNION MEDICAL SHENZHEN CO., LTD.: PRODUCTS OFFERED
    • 12.1.14 SPECTRUM MEDICAL TECHNOLOGIES
    • TABLE 177 SPECTRUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
    • TABLE 178 SPECTRUM MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
    • 12.1.15 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.
    • TABLE 179 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: COMPANY OVERVIEW
    • TABLE 180 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: PRODUCTS OFFERED
  • 12.2 OTHER PLAYERS
    • 12.2.1 SCW MEDICATH LTD.: COMPANY OVERVIEW
    • 12.2.2 VYGON: COMPANY OVERVIEW
    • 12.2.3 NANJING FOINOE CO., LTD.: COMPANY OVERVIEW
    • 12.2.4 LEMER PAX: COMPANY OVERVIEW
    • 12.2.5 COMECER S.P.A.: COMPANY OVERVIEW
    • 12.2.6 TEMA SINERGIE S.P.A.: COMPANY OVERVIEW
    • 12.2.7 SHEEN MAN CO., LTD.: COMPANY OVERVIEW
    • 12.2.8 HONG KONG MEDI CO., LTD.: COMPANY OVERVIEW
    • 12.2.9 QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
    • 12.2.10 SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD: COMPANY OVERVIEW
  • *Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS